33 results
424B3
PPBT
Purple Biotech Ltd
14 Nov 23
Prospectus supplement
4:13pm
in France and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s
F-1/A
PPBT
Purple Biotech Ltd
13 Nov 23
Registration statement (foreign) (amended)
4:11pm
and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s Vice President
F-1
PPBT
Purple Biotech Ltd
30 Oct 23
Registration statement (foreign)
4:30pm
and completed his academic training with a post-doctoral fellowship at Imperial College, London.
Ido Morpurgo has served as the Company’s Vice President
6-K
EX-99.1
PPBT
Purple Biotech Ltd
1 May 23
Notice of Annual General Meeting of Shareholders
4:00pm
subsidize ongoing corporate governance or other professional training for directors in amounts up to US$5,000 per director per annum, and we reimburse
6-K
EX-99.1
gmz0mrfj5wh1kvl99
18 Jul 22
Notice of Annual General Meeting of Shareholders
4:25pm
6-K
EX-99.1
294ziqeg5ll
9 Dec 21
Purple Biotech Appoints Senior Business Development Executive Fabien Sebille as Chief Business Officer
7:30am
6-K
EX-99.1
0a6emd
10 Nov 21
Notice of Annual General Meeting of Shareholders
4:45pm
20-F/A
lv42l0 2x84f
16 Mar 21
Annual report (foreign) (amended)
3:22pm
6-K
EX-99.2
z04wnxp
22 Oct 20
Notice of Annual General Meeting of Shareholders
4:10pm
424B4
cy623
16 Mar 20
Prospectus supplement with pricing info
6:08am
F-1/A
9ufn14i5qbz
11 Mar 20
Registration statement (foreign) (amended)
9:16am
F-1/A
b4zm07roze j5p
10 Mar 20
Registration statement (foreign) (amended)
8:13am
6-K
EX-99.1
67zal ciajya106keva
11 Feb 20
Kitov Pharma Provides Corporate Update and Reports Full-Year 2019 Financial Results
7:01am
424B3
sl4mbdj jn0lc0kmy
27 Dec 19
Prospectus supplement
4:30pm
F-1
rqh8ezsjcgatn3jopf
27 Dec 19
Registration statement (foreign)
4:09pm
6-K
EX-99.1
5fgik9j34 yp
19 Nov 19
Report of Foreign Private Issuer
4:31pm